The HIV agent dolutegravir (Tivicay) was tied to greater viral suppression for pregnant patients with HIV-1, according to a cohort study. Among patients who used dolutegravir during pregnancy, viral ...
Please provide your email address to receive an email when new articles are posted on . Results of a three-armed trial demonstrated that dolutegravir-based ART regimens are favorable to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback